University of KwaZulu-Natal - Facts About STD's

WASHINGTON (Reuters) - A gel made using Gilead Sciences Inc's HIV drug tenofovir reduced HIV infections in women by 39 percent over two and a half years -- the first time such an approach has protected against the virus, South African researchers ...